ProfileGDS4718 / 242159_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 60% 58% 54% 60% 59% 57% 58% 56% 55% 60% 57% 50% 60% 57% 59% 58% 56% 59% 56% 59% 57% 57% 59% 55% 55% 56% 58% 54% 56% 59% 59% 58% 61% 62% 55% 57% 60% 53% 60% 51% 61% 56% 55% 54% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1108260
GSM549102patient 115, normal, homogenized [OPG study]5.99958
GSM549104patient 119, normal, homogenized [OPG study]5.7236854
GSM549108patient 138, normal, homogenized [OPG study]6.1169460
GSM549119patient 077, normal, homogenized [OPG study]6.0806959
GSM549133patient 032, cancer, homogenized [OPG study]5.894357
GSM549139patient 042, cancer, homogenized [OPG study]6.0139758
GSM549099patient 107, normal, homogenized [OPG study]5.8446556
GSM549109patient 139, normal, homogenized [OPG study]5.850455
GSM549110patient 046, normal, homogenized [OPG study]6.133460
GSM549114patient 063, normal, homogenized [OPG study]5.8541557
GSM549122patient 082, normal, homogenized [OPG study]5.5023250
GSM549134patient 033, cancer, homogenized [OPG study]6.0920860
GSM549136patient 036, cancer, homogenized [OPG study]5.8986957
GSM549140patient 044, cancer, homogenized [OPG study]6.0089459
GSM549111patient 047, normal, homogenized [OPG study]6.0062658
GSM549113patient 057, normal, homogenized [OPG study]5.8045956
GSM549132patient 031, cancer, homogenized [OPG study]6.0342359
GSM549137patient 038, cancer, homogenized [OPG study]5.8470156
GSM549142patient 047, cancer, homogenized [OPG study]6.1809159
GSM549100patient 110, normal, homogenized [OPG study]5.9164557
GSM549107patient 135, normal, homogenized [OPG study]5.8921357
GSM549115patient 068, normal, homogenized [OPG study]6.0624259
GSM549116patient 072, normal, homogenized [OPG study]5.8215655
GSM549120patient 078, normal, homogenized [OPG study]5.8037755
GSM549131patient 030, cancer, homogenized [OPG study]5.8669556
GSM549118patient 074, normal, homogenized [OPG study]5.9704158
GSM549129patient 027, cancer, homogenized [OPG study]5.7831354
GSM549123patient 088, normal, homogenized [OPG study]5.894156
GSM549124patient 006, cancer, homogenized [OPG study]6.1011459
GSM549126patient 015, cancer, homogenized [OPG study]6.0519959
GSM549128patient 025, cancer, homogenized [OPG study]5.9789858
GSM549103patient 117, normal, homogenized [OPG study]6.2040261
GSM549117patient 073, normal, homogenized [OPG study]6.1829762
GSM549138patient 041, cancer, homogenized [OPG study]5.7868855
GSM549141patient 045, cancer, homogenized [OPG study]5.9421557
GSM549130patient 028, cancer, homogenized [OPG study]6.1008760
GSM549101patient 111, normal, homogenized [OPG study]5.692553
GSM549105patient 128, normal, homogenized [OPG study]6.1467960
GSM549106patient 134, normal, homogenized [OPG study]5.5390651
GSM549112patient 048, normal, homogenized [OPG study]6.1693661
GSM549125patient 011, cancer, homogenized [OPG study]5.87456
GSM549127patient 024, cancer, homogenized [OPG study]5.8565355
GSM549135patient 035, cancer, homogenized [OPG study]5.7081254